Justin Zelin

Stock Analyst at BTIG

(0)
# 4288
Out of 5,218 analysts
43
Total ratings
22.22%
Success rate
-7.95%
Average return
Main Sectors:
Top Industries:
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
Enliven Therapeutics
Initiates Coverage On: Buy
42
23.25 80.65% 1 Dec 13, 2024
CARISMA Therapeutics
Downgrades: Neutral
n/a
n/a n/a 2 Dec 10, 2024
Poseida Therapeutics
Downgrades: Neutral
n/a
n/a n/a 2 Nov 26, 2024
IDEAYA Biosciences
Maintains: Strong Buy
55 62
25.19 146.13% 2 Jul 9, 2024
Jasper Therapeutics
Initiates Coverage On: Buy
90
20.51 338.81% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.87 318.12% 1 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
100 125
46.98 166.07% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Dec 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
27
4.49 501.34% 1 Nov 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 16
0.19 8321.05% 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
85 91
28.93 214.55% 2 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 10
0.97 930.93% 2 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
1.81 783.98% 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
30 37
7.7 380.52% 2 Jul 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 35
13.89 151.98% 1 Jun 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
85 90
35.19 155.75% 2 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
9.6 222.92% 1 May 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 16
106.85 -85.49% 1 Mar 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Dec 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 10
3.23 209.6% 3 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
n/a n/a 1 Jul 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
17
n/a n/a 1 May 18, 2021